In an interview with Applied Clinical Trials Associate Editor Don Tracy, Samuel Salvaggio Senior Trial Design Lead, One2Treat, discusses partnerships that remain vital for guaranteeing success in ...
The ongoing evolution of real-world evidence from a novel concept to a cornerstone of modern medical research signifies its ...
In this video interview, Dominique Demolle, CEO of Cognivia, discusses challenges that sponsors are currently facing with adherence and some strategies that can help address them.
Machine learning can help investors dive deeper into trial data to evaluate the true potential of an asset and uncover new ...
In an interview with Applied Clinical Trials Associate Editor Don Tracy, Samuel Salvaggio, Senior Trial Design Lead, ...
Five-year data from the POETYK PSO long-term extension trial confirm the sustained efficacy and safety of Sotyktu ...
In an interview with ACT senior editor Andy Studna at SCOPE Summit, Rajneesh Patil, vice president, digital innovation, IQVIA ...
In an interview with ACT senior editor Andy Studna at SCOPE Summit, Garty, chief technology officer, clinical data, Veeva Systems, discusses clinical data trends for 2025 and simplifying management ...
Updated data from the Phase III TALAPRO-2 trial show that the combination of Talzenna (talazoparib) and Xtandi (enzalutamide) significantly improves overall survival in patients with metastatic ...
Recent actions by the FDA and NIH in response to the current political climate have left key stakeholders in clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback